Abano Healthcare Group Limited reported consolidated and standalone earnings results for the year ended May 31, 2012. For the period, in consolidated, the company reported revenue of NZD 206,367,000 against NZD 174,792,000 a year ago. Operating profit was NZD 17,443,000 against NZD 13,375,000 a year ago. Profit before income tax was NZD 8,218,000 against NZD 17,172,000 a year ago. Profit for the year attributable to equity holders of the company share of profit was NZD 1,612,000 against NZD 11,464,000 a year ago. Basic and diluted earnings per share from continuing operation was 10.07 cents. Underlying net profit after tax was NZD 3.0 million against NZD 3.1 million a year ago. EBITDA was NZD 25.7 million against NZD 19.8 million a year ago. Underlying EBITDA was NZD 27.3 million against NZD 20.6 million a year ago. Net cash generated from operating activities was NZD 20,623,000 against NZD 16,088,000 a year ago. Purchase of intangible assets and property, plant and equipment was NZD 6,890,000 against NZD 11,436,000 a year ago. Net debt as on May 31, 2012 was NZD 76.3 million compared to NZD 49.5 million as on May 31, 2011. For the period, on standalone basis, the company reported revenue of NZD 382,000 against NZD 174,792,000 a year ago. Operating profit was NZD 8,989,000 against NZD 13,375,000 a year ago. Loss before income tax was NZD 4,205,000 against profit before income tax of NZD 4,255,000 a year ago. Loss for the year attributable to equity holders of the company share was NZD 3,203,000 against profit for the year attributable to equity holders of the company share of profit NZD 671,000 a year ago. Negative net cash generated from operating activities was NZD 3,731,000 against NZD 2,528,000 a year ago. Purchase of intangible assets and property, plant and equipment was NZD 7,000 against NZD 21,000 a year ago. Net debt as on May 31, 2012 was NZD 16.7 million compared to NZD 13.2 million as on May 31, 2011. The board has confirmed an annual dividend of 21 cents per share for the year, demonstrating the board's confidence in the underlying growth of NPAT. Therefore a fully imputed final dividend of 13.7 cents per share will be paid on August 24, 2012. August 10, 2012 is record date for dividend. The company also announced that revenue growth expected to continue at double digit rates for the fiscal 2013. Breakeven expected in two to three years.